Antepartum care (third trimester): Clinical sciences

Last updated: January 30, 2025

Antepartum care (third trimester): Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Third trimester antepartum care refers to pregnancy care from 28 weeks of gestation through the end of pregnancy. Care during this time is critical to monitor for high-risk conditions and prepare for delivery. All patients in the third trimester warrant consideration of additional ultrasounds; screening tests; assessment of fetal well-being; counseling on birth plans; trimester-specific pregnancy education; and counseling on postpartum contraception.

When assessing a patient presenting for a third trimester antepartum visit, your first step is to obtain a focused history and physical. The history should include asking whether they’re experiencing contractions, possible leakage of fluid, vaginal bleeding, and appropriate fetal movements.

Additionally, patients may report common benign pregnancy symptoms, such as Braxton Hicks contractions, back aches, round ligament pain, edema, acid reflux, and mild shortness of breath

Here's a clinical pearl! Braxton Hicks contractions, often referred to as “false labor,” present with infrequent and minimally painful tightening of the abdomen. On the flip side, contractions representing “true labor” are painful, regular, and increase in frequency over time. Typically, false labor is felt only in the front of the abdomen, while true labor is felt in the lower back as well as the abdomen.

Your physical exam should include a review of weight, since both insufficient and excessive weight gain can lead to complications. Also, pay attention to blood pressure, as new elevations could indicate gestational hypertension or preeclampsia. Perform fetal Doppler assessment at each visit and follow up on any abnormality with prolonged monitoring.

With the focused history and physical complete, it’s time to initiate third trimester antepartum care.

For patients with abnormal fundal heights or those with conditions that raise the risk of macrosomia or growth restriction, growth ultrasounds are done every 3 to 4 weeks. Some patients may have had a prior ultrasound that showed an abnormality, such as placenta previa or a fetal anomaly, so reassess any previous abnormalities in the third trimester. While uncommon, some patients with insufficient prenatal care get to the third trimester without having an ultrasound and require assessment of their due date.

Here's a clinical pearl! In the third trimester, the due date is assessed by comparing the gestational age calculated by the last menstrual period to fetal biometry, meaning an assessment of the fetal head, abdomen, and extremities. For pregnancies at 28 weeks and beyond that have not previously had ultrasound confirmation of their due date, assign a new due date if the gestational age by ultrasound is more than 21 days off from menstrual dates.

Keep in mind that in cases where there is no ultrasound confirmation of dates before 22 weeks of gestation, the pregnancy would be considered suboptimally dated. This means that timing for indicated deliveries, such as those with preeclampsia, should be based on the best clinical estimates. Also, suboptimally dated pregnancies are not candidates for elective delivery after 39 weeks and 0/7 days.

Next up, let’s talk about different screening assessments in the third trimester. If not already done in the second trimester, be sure to order a CBC around 28 weeks to reassess for anemia, as well as a glucose tolerance test to screen for gestational diabetes. Patients at high-risk for infectious diseases need repeat screening for HIV, syphilis, gonorrhea, and chlamydia. Unless a patient is already known to be a carrier of group B streptococcus, collect a vaginal-rectal swab between 36 and 38 weeks.

Additionally, assess fetal presentation at approximately 36 weeks by palpating through the Leopold maneuvers, or by a limited ultrasound exam if the patient’s body habitus prevents adequate assessment. If the fetus has a breech presentation or transverse lie at or after 36 weeks, counsel on the external cephalic version, or ECV. Finally, repeat depression and intimate partner violence screening as well, usually at the 28-week visit.

Here’s another clinical pearl! ECV is a procedure performed after 37 weeks, where providers will attempt to move the fetus into a cephalic presentation by applying external pressure on the patient's abdomen. ECV is elective, meaning that after you explain the risks and benefits, your patient can choose to have it performed in order to prevent a c-section. If ECV fails, or if the patient declines, the next step for delivery would be a c-section

Sources

  1. "Committee Opinion No. 700: Methods for estimating the due date" Obstet Gynecol (2017)
  2. "Guidelines for perinatal care, 8th ed." ACOG (2017)